Anxiety

Rethinking the Cause of Anxiety

Women presenting in perimenopause are frequently labeled as having “primary” anxiety when the clinical picture may be more layered. Low estrogen levels can lead to symptoms that closely resemble anxiety and depression:

In some cases, psychopharmacology and psychotherapy are appropriate. However, if the hormonal context is ignored, the clinician may miss an important driver of symptom onset or symptom persistence. The key question is not whether symptoms are “psychiatric” or “hormonal.” The key question is whether hormonal change is materially contributing to psychiatric symptom expression in that patient [2].

Estradiol and the neurobiology of anxiety

Estradiol is not merely a reproductive hormone. It is a neuroactive steroid with widespread effects on brain regions involved in mood regulation, thought processing, sleep, cognition, and autonomic tone. Mechanistically, estradiol appears relevant to anxiety and depressive symptoms through several pathways:

Estradiol modulates serotonergic signaling, including serotonin synthesis, receptor expression, and transporter-related function. It also influences dopaminergic and noradrenergic systems, which are relevant to motivation, arousal, reward, and affect regulation. In addition, estradiol interacts with GABAergic and glutamatergic signaling, affects hypothalamic-pituitary-adrenal axis responsivity, and appears to support neuroplasticity through effects on neurotrophic signaling such as BDNF. Taken together, estrogen withdrawal or marked fluctuation may reduce resilience in neural circuits that regulate mood and anxiety. [4,5]

From a pathophysiologic standpoint, this helps explain a common clinical observation: some women do not simply report “sadness” in perimenopause. They report a new internal sense of dysregulation, racing thoughts, panic-like symptoms, reduced frustration tolerance, insomnia, and feeling emotionally unlike themselves. In susceptible patients, estradiol fluctuation may lower the threshold for these symptoms by destabilizing serotonergic tone, increasing stress reactivity, worsening sleep, and amplifying vasomotor symptoms that further fragment mood regulation. [3]

Clinical Case Illustration: A Patient’s Journey

One patient’s story highlights this connection. After years of emotional struggle, multiple medications, and little relief, she discovered that her symptoms were linked to estrogen deficiency.

Following a hysterectomy, her health declined dramatically. She experienced severe depression, fatigue, weight gain, headaches, and a loss of joy in life. Despite seeing multiple physicians and trying several antidepressants including Prozac, Effexor, Zoloft, and Cymbalta, and yet, her symptoms persisted. It wasn’t until she began working with my practice that things changed.

Through a structured lifestyle program and gradual restoration of estrogen and progesterone levels, her health transformed. Within just one month, her depression lifted. By three months, she felt energized, social, and emotionally alive, experiencing a level of vitality she had never known before.

A Useful Clinical Framework: Introducing Physiologic Estrogen Restoration Therapy

Physiologic Estrogen Restoration Therapy is an approach that focuses on restoring estradiol and progesterone in a manner intended to more closely reflect endogenous physiology. Rather than focusing solely on symptom management, this framework considers whether hormonal changes may be contributing to the clinical presentation, particularly in perimenopausal and menopausal women.

In practice, many patients may report improvements in areas such as mood, anxiety, sleep, and energy when hormonal factors are addressed.

A Shift in How We Think About Mental Health

This framework invites clinicians to broaden the differential when evaluating anxiety and depression in midlife women. Rather than assuming a purely psychiatric etiology, it considers the possibility that neuroendocrine changes may be contributing to symptom onset or severity.

This perspective does not replace established treatments. Psychotherapy and pharmacologic interventions remain important components of care. Instead, it supports a more comprehensive model in which hormonal health is evaluated alongside other biologic and psychosocial factors.

For some patients, this integrated approach may help clarify the drivers of symptoms and inform more individualized treatment strategies.

References